RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest.